Approaches to successful total knee arthroplasty in haemophilia A patients with inhibitors.
Konkle
B A
BA
Penn Comprehensive Hemophilia and Thrombosis Program, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. konkleb@mail.med.upenn.edu
Nelson
C
C
Forsyth
A
A
Hume
E
E
D000328:Adult; D000818:Animals; D019645:Arthroplasty, Replacement, Knee / Q000379:methods*; D001323:Autoantibodies / Q000097:blood*; D019774:Blood Coagulation Factor Inhibitors / Q000097:blood*; D005167:Factor VII / Q000627:therapeutic use*; D005169:Factor VIII / Q000627:therapeutic use; D015942:Factor VIIa; D006467:Hemophilia A / Q000097:blood* / Q000601:surgery; D006488:Hemostasis, Surgical / Q000379:methods*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000627:therapeutic use*; D013552:Swine; D016896:Treatment Outcome
D001323:Autoantibodies; D019774:Blood Coagulation Factor Inhibitors; D011994:Recombinant Proteins; D005167:Factor VII; D005169:Factor VIII; C103587:recombinant FVIIa; D015942:Factor VIIa